NCT00079001
Clinical Trial Information
Trial Number: NCT00079001 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone
Study ID:
CALGB-90202
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00079001-D4 | Data submissions NCT00079001-D1, -D2, and -D3 can be used to reproduce the results from CALGB-90202’s primary publication 24590644. Data submission NCT00079001-D4 contains additional data collected on the trial that were not published. NCT00079001-D4 includes data on type of progression and clinical follow-up. Patients in all these data submissions have the same deidentified patient IDs. |
| NCT00079001-D3 | NCT00079001-D3-Dataset.csv (ae) is one of 3 datasets that contain the data published in the analyses of PubMed ID 24590644. This dataset contains information that will allow you to reproduce the toxicity reported. |
| NCT00079001-D2 | NCT00079001-D2-Dataset.csv (analysis) is one of 3 datasets that contain the data published in the analyses of PubMed ID 24590644. This dataset contains information that will allow you to reproduce the primary analysis and time-to-event analysis. |
| NCT00079001-D1 | NCT00079001-D1-Dataset.csv (baseline) is one of 3 datasets that contain the data published in the analyses of PubMed ID 24590644. This dataset contains information that will allow you to reproduce the baseline characteristics table. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®